OMB control number
Biosimilar User Fee Program
OMB 0910-0718 · HHS/FDA.
OMB 0910-0718
This information collection supports the Food and Drug Administration’s (FDA, us or we) Biosimilars User Fee Program. Respondents to the collection are applicants or sponsors of biosimilar product marketing applications subject to statutory and regulatory requirements administered by FDA.
The latest form for Biosimilar User Fee Program expires 2028-07-31 and can be found here.
Latest Forms, Documents, and Supporting Material
Document Name |
|---|
Form and Instruction |
Supporting Statement A |
All Historical Document Collections
| Revision of a currently approved collection | 2025-01-31 | ||
|
Approved without change |
Revision of a currently approved collection | 2021-12-23 | |
|
Approved without change |
Revision of a currently approved collection | 2018-12-06 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2018-01-04 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2017-08-08 | |
|
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2016-08-04 | |
|
Approved without change |
Extension without change of a currently approved collection | 2015-06-23 | |
|
Approved with change |
New collection (Request for a new OMB Control Number) | 2012-06-20 |
OMB Details
Biosimilar User Fee Cover Sheet (Form FDA 3792) & Annual Survey
Federal Enterprise Architecture: Health - Health Care Services
| Form Form FDA 3792 | Biosimilar User Fee Cover Sheet | Fillable Fileable | Form and instruction |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.